Clinical Trial Update: Current Status of BTKi Treatment for CLL/SLL in China

View source ↗

Summary

An update on a Bruton tyrosine kinase inhibitor (BTKi) trial for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) in China, showing the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: CLL/SLL | Status: RECRUITING